Remedy Robotics, Mission Thrombectomy extend N1 System to blood clot removal - The Robot Report

Remedy Robotics Inc. has partnered with Mission Thrombectomy to expand access to endovascular thrombectomy, a critical procedure for removing blood clots in stroke patients, both in the U.S. and globally. Remedy will serve as Mission Thrombectomy’s exclusive robotics partner, collaborating closely with its extensive clinical network spanning over 100 countries and the Society of Vascular and Interventional Neurology (SVIN). The partnership aims to integrate Remedy’s N1 System—a remotely operated endovascular robot combining proprietary hardware and AI-enabled software—into stroke-thrombectomy workflows to improve the speed, safety, and effectiveness of treatment, especially in underserved regions. Endovascular thrombectomy is the most effective treatment for severe ischemic strokes but remains inaccessible to many; only about one-third of Americans have timely access, and less than 1% of people in low-income countries can receive it. Remedy Robotics and Mission Thrombectomy seek to address this disparity by leveraging Remedy’s telerobotic technology alongside Mission Thromb